AirSculpt Technologies (NASDAQ:AIRS) Coverage Initiated by Analysts at Lake Street Capital

Key Points

• Lake Street Capital initiated coverage of AirSculpt Technologies with a “buy” rating and a $3.00 price target, implying approximately 108% upside from the reported $1.44 share price.
• Analyst opinion remains mixed: AirSculpt has Buy, Hold and Sell ratings, resulting in a consensus “Hold” rating and a $3.75 target price.
• The company’s latest quarterly results fell short of expectations, with adjusted EPS of $0.01 versus $0.02 expected and revenue of $42.9 million versus a $44.14 million consensus estimate; institutional investors own 91.54% of the stock.

Research analysts at Lake Street Capital assumed coverage on shares of AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) in a research report issued on Thursday, Briefing.com reports. The brokerage set a "buy" rating and a $3.00 price target on the stock. Lake Street Capital's price target points to a potential upside of 108.33% from the company's current price.

AIRS has been the topic of several other reports. Weiss Ratings reissued a "sell (d-)" rating on shares of AirSculpt Technologies in a report on Monday, September 28th. Wall Street Zen downgraded AirSculpt Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, August 15th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $3.75.

AirSculpt Technologies Trading Up 13.4%

Shares of NASDAQ:AIRS opened at $1.44 on Thursday. The company has a market capitalization of $103.82 million, a P/E ratio of -8.00 and a beta of 2.29. AirSculpt Technologies has a 1 year low of $1.15 and a 1 year high of $11.93. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.79 and a quick ratio of 0.79. The business's 50 day simple moving average is $2.04 and its 200 day simple moving average is $3.12.

AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.01 EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.01). The company had revenue of $42.90 million for the quarter, compared to the consensus estimate of $44.14 million. AirSculpt Technologies had a negative return on equity of 5.83% and a negative net margin of 7.79%.

Institutional Investors Weigh In On AirSculpt Technologies

A number of large investors have recently modified their holdings of AIRS. Royal Bank of Canada boosted its stake in AirSculpt Technologies by 259.6% in the first quarter. Royal Bank of Canada now owns 9,879 shares of the company's stock valued at $28,000 after buying an additional 7,132 shares in the last quarter. AXQ Capital LP bought a new position in AirSculpt Technologies in the second quarter valued at about $46,000. Hsbc Holdings PLC acquired a new position in AirSculpt Technologies during the second quarter worth about $63,000. Waverly Advisors LLC acquired a new position in AirSculpt Technologies during the second quarter worth about $101,000. Finally, Bank of New York Mellon Corp acquired a new position in AirSculpt Technologies during the second quarter worth about $117,000. Institutional investors and hedge funds own 91.54% of the company's stock.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc operates a medical aesthetics business focused on body-contouring and cosmetic procedures. Through its AirSculpt brand, the company provides minimally invasive liposuction and fat-transfer treatments designed to remove unwanted fat and reshape areas of the body.

Its services also include procedures such as skin tightening and other elective aesthetic treatments, with offerings varying by location and patient needs. AirSculpt markets its procedures directly to consumers and provides consultations, treatment planning and follow-up care through its network of company-operated centers.

The company was founded in 2015 by plastic surgeon Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.